$5.27
+0.37 (+7.55%)
ANGX News7 articles
Angels' $4B Deal Puts Braves' Valuation in Perspective
A reported $4 billion price for the Angels aligns closely with Atlanta Braves Holdings' enterprise value, but the comparison is less bullish once debt and non-baseball assets are considered.
Ultragenyx Plunges 44% as Angelman Gene Therapy Fails Phase 3 Trial
Ultragenyx's stock plummeted 44% after its Phase 3 apazunersen trial failed, wiping out $1.14 billion in market cap. The company now faces major cost cuts.
Angelini Completes $4.1B Catalyst Buyout, Delists From Nasdaq
Angelini Pharma has finalized its $4.1 billion all-cash acquisition of Catalyst Pharmaceuticals, delisting the stock from Nasdaq. The deal reflects an enterprise value of about 5.1 times projected 2026 revenue.
Catalyst Pharmaceuticals Delisted After Angelini Merger Closes
Catalyst Pharmaceuticals was delisted from Nasdaq after Angelini Pharma completed its $4.1 billion acquisition. The stock closed at $31.49, just one cent below the $31.50 cash payout.
Angelini Completes $4.1B Acquisition of Catalyst Pharmaceuticals
Angelini finalized its $4.1 billion acquisition of Catalyst Pharmaceuticals, paying $31.50 per share in cash, valuing the company at 9x 2026 EBITDA.
American Airlines Suspends Pittsburgh-Los Angeles Flights Amid Fuel Cost Surge
American Airlines (AAL) suspends daily Pittsburgh-Los Angeles flights from Aug. 5 to Oct. 4 due to high jet fuel costs, trimming a key West Coast route as fuel expenses surge over $4 billion.
AEP Texas Resolves San Angelo Blackout Amid Rising Texas Demand
AEP Texas restored power to nearly all Tom Green County customers after a substation failure cut service to 7,800 in San Angelo. The outage comes as AEP faces scrutiny over Texas demand and a $78B capital plan.